Intel Rallies 157% as Foundry Strategy Faces Validation Test
Intel shares have surged 157% this year, driven by renewed confidence in its manufacturing pivot. While a prominent analyst projects a path to $200, the majority of Wall Street remains cautious, citing the lack of signed external customers for the new 14A process.
Intel (INTC) has emerged as one of the strongest performers in the semiconductor sector, with shares climbing approximately 157% year-to-date. This rally reflects growing investor conviction in the company’s dual strategy of reviving its internal product business while scaling its contract manufacturing arm, Intel Foundry. The stock’s recent strength has outpaced many peers, positioning Intel as a key player in the ongoing shift toward advanced chip fabrication.
Despite the significant price increase, a subset of analysts believes the upside is not exhausted. Melius Research, citing data from GN markets/earnings (en-US), has issued a target that significantly exceeds the current consensus. This view contrasts with the broader market sentiment, where most institutions maintain a neutral stance due to execution risks associated with the foundry transition.
Bullish Valuation Based on Foundry Potential
Melius Research analyst Ben Reitzes maintains a Buy rating with a $165 price target, implying a 70% increase from levels near $97. He further projects a potential valuation of $200 within two years, a figure derived from summing the individual values of Intel’s two distinct business units. Reitzes estimates that both the product division and the foundry segment could independently justify valuations exceeding $80 per share.
This aggressive projection relies on specific operational milestones. The foundry business must secure high-volume commitments from major clients, including potential partners such as Apple, Tesla, and large cloud providers, for the next-generation 14A process. Simultaneously, the product business must sustain price increases for AI-capable personal computers and server chips to push earnings above $4 per share. These outcomes are critical for validating the sum-of-the-parts valuation model.
Consensus Remains Cautious on Execution Risks
The broader analyst community remains divided on Intel’s trajectory. Among approximately 32 covering analysts, 23 rate the stock a Hold, while only seven recommend a Buy. The average price target stands at $117.56, significantly lower than Melius’ projection. This conservative stance reflects skepticism regarding the company’s ability to execute its manufacturing strategy at scale without substantial external validation.
Mizuho’s Vijay Rakesh exemplifies this cautious approach, maintaining a Hold rating with a $92 target. He describes the stock as fairly valued following its recent rally, emphasizing that Intel has not yet signed the outside foundry customers necessary to prove its manufacturing model. The absence of definitive contracts for the 18A or 14A nodes remains a primary concern for investors weighing the long-term viability of the foundry business.
Recent Results Signal Improving Operational Metrics
Intel’s most recent quarterly results provided some support for the bullish narrative, with revenue rising approximately 25% year-over-year. Adjusted earnings also exceeded market estimates, indicating improved operational efficiency. Management has signaled confidence in this trajectory, with CEO Lip-Bu Tan purchasing roughly $10 million in stock at $95 per share in August. The company also raised about $20 billion in a share sale at the same price to fund its factory buildout.
Speculation regarding additional foundry customers has added volatility to the stock. Reports suggested that SK Hynix might lease space at Intel’s planned Ohio plant, though the company quickly clarified that no matters had been determined. Investors will continue to monitor the signing of major external customers and the scaling of production output as key indicators of whether the foundry strategy can deliver the projected returns.
